Privately-held drug developer LIB Therapeutics has claimed FDA approval for a new once-monthly PCSK9 inhibitor – Lerochol – that can be used to reduce cholesterol levels. The injectable product has ...
LIB Therapeutics has passed another milestone on its path to launching a challenger to cholesterol drugs sold by Amgen, Regeneron and Sanofi. In the latest phase 3 readout, the private biotech’s ...
Lib’s Grill, the local restaurant chain with roots in Perry Hall, will add a Carroll County outpost next spring. Owner Nick Liberatore said this week that he has plans to open a fourth location of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results